Defining the Protein Regulome Targeted by Lactate and Other Central Carbon Oncometabolites 2024 Emerging Leader Award Edward Chouchani, PhD, Dana-Farber Cancer Institute Read More
Spatiotemporal Profiling of the Aged Microenvironment in Tumor Dormancy and Recurrent Disease 2023 PARTNERSHIP WITH THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION AND THE MELANOMA RESEARCH ALLIANCE Ashani Weeraratna, PhD, Johns Hopkins University; Arjun Raj, PhD, University of Pennsylvania Read More
Improving Breast Cancer Outcomes by Understanding How Immune Age Impacts Tumor Evolution and Response to Therapy 2023 PARTNERSHIP WITH THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION Sandra McAllister, PhD, Brigham & Women’s Hospital; Kornelia Polyak, MD, PhD; Rachel Freedman, MD, Dana-Farber Cancer Institute Read More
Age-Related Clonal Hematopoiesis as a Driver of Breast Cancer Awakening and Metastatic Relapse 2023 PARTNERSHIP WITH THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION Julio Aguirre-Ghiso, PhD, Albert Einstein College of Medicine; Ross Levine, MD, Memorial Sloan Kettering Cancer Center Read More
Epigenetic and Metabolic Vulnerabilities in High-Risk Pediatric Acute Myeloid Leukemia 2023 PARTNERSHIP WITH GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH Jeffrey Magee, MD, PhD, Grant Challen, PhD, Stephen Sykes, PhD, Washington University in St. Louis Read More
Chromatin Remodeling INO80 Complex as Targeted Therapeutics Platform in Hematologic Malignancies 2023 PARTNERSHIP WITH GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH David Dominguez-Sola, MD, PhD, Icahn School of Medicine at Mount Sinai-Tisch Cancer Institute; Daniel Herranz-Benito, PharmD, PhD, Rutgers Cancer Institute of New Jersey Read More
